Guidelines & Policies

Click to view:

* Guidelines on the Prevention, Control, and Management of Potential Rabies Exposures

* PIDSP Advisory for Physicians on the Management of Children with Potential Leptospirosis Exposure August 25, 2026

* Statement of Support for the Department of Health’s “One Shared Commitment” Measles-Rubella Supplemental Immunization Activity (MR-SIA) Phase III 31 July 2026

*  PIDSP Statement of Support for the Department of Health’s “Ligtas Tigdas” Measles-Rubella Supplemental Immunization Activity 25 June 2026

* Chikungunya Advisory for Parents English Version / Tagalog Version

* Advisory for Parents on COVID19 English Version / Tagalog Version

* Correction to the PPS-PIDSP-PFV Childhood Immunization Calendar 2026 July 1,2026

* PPS & PIDSP Statement of Support for the DOH “Ligtas Tigdas” Campaign 22 January 2026 English Version / Cebuano Version

*  Revised Childhood Immunization Schedule 2026 July 1,2026

*  PIDSP Clinical Advisory on the Rising Influenza Activity in the Philippines 13 Oct 2025

*  PPS-PIDSP Advisory on the Increasing Cases of Measles in the Country 18 Feb 2025

*  PPS-PIDSP Statement of Support for the DOH Vaccination Catch-Up Efforts and Bakuna Eskwela Program 08 November 2024

*  DOH Immunization Campaign 2024

*  Childhood Immunization Schedule 2025

*  PPS-PIDSP Advisory on the Increasing Cases of COVID-19 Infections May 2024

*  PPS-PIDSP Joint Position Statement on Measles in the Community: Guidance for Healthcare Providers 27 March 2024

*  PPS-PIDSP Joint Position Statement on the Increasing Cases of Pertussis in the Community: Guidance for Healthcare Providers 26 March 2024 (Version 2)

*  PPS-PIDSP Joint Position Statement On The Increasing Cases Of Pertussis  In The Community: Guidance For  Healthcare Providers 24 MARCH 2024

*   Childhood Immunization Schedule 2024   

* National Deworming Month  English Version / Tagalog Version

* World Immunization Week – Common Questions About Vaccines  English Version / Tagalog Version

*  Childhood Immunization Schedule 2023    

*  PPS/PIDSP/PFV Recommendation for Covid-19 Vaccination in Children and Adolescents 5-17 years old 06 March 2023    

* PIDSP-PPS Position Paper on Optional Masking Indoors in Schools 04 November 2022    

* Surveillance and Analysis of COVID-19 in Children Nationwide – Case Bulletin #5  

* Clinical Practical Guidelines on Leptospirosis in Children 

* 2021 Clinical Practice Guidelines in the Evaluation and Management of Pediatric Community-Acquired Pneumonia 

* Surveillance and Analysis of COVID-19 in Children Nationwide – Case Bulletin #4  

* Childhood Immunization Schedule 2022  Version  17 February 2022 

* PPS-PIDSP Joint Position Statement on COVID-19 Vaccination for Children 4 February 2022 

* PPS-PIDSP Joint Position Statement on COVID-19 Vaccination for Children ages  5 to 11 years old  

* Interim Guidelines on the Screening, Classification, and Clinical Management of Pediatric Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) Version 5, 08 January 2022 

* PPS-PIDSP Statement on Ramping Up the National Immunization Program: A Call to Action 

* Childhood Immunization Schedule 2021  Version  26 November 2021 

* PPS-PIDSP Statement on COVID-19 Vaccines for Children 11 November 2021  

* Surveillance and Analysis of COVID-19 in Children Nationwide – Case Bulletin #3  

* PPS-PIDSP Statement on COVID-19 Vaccines for Children 6 September 2021  

* Surveillance and Analysis of COVID-19 in Children Nationwide – Case Bulletin #2  

* PPS-PIDSP Statement on COVID-19 Vaccines for Children 7 June 2021  

* Surveillance and Analysis of COVID-19 in Children Nationwide – Case Bulletin #1  

* Childhood Immunization Schedule 2021  

* Interim Guidelines on the Screening, Assessment and Clinical Management of  Pediatric Patients with Suspected or Confirmed Coronavirus Disease 2019  (COVID-19) Version 4.0  6 February 2021  

* PPS/PIDSP Statement on the Relaxation of Age-Based Restrictions 23 January 2021 

* Algorithm on the Screening,Classification and Management of Pediatric Patients with Suspected COVID-19 ( V3.1, 31 August 2020 ) 

*  Interim Guidelines on the Screening, Assessment and Clinical Management of Pediatric Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) Version 3.1 , 31 August 2020 

*  Infection Control and Prevention of  COVID-19 Transmission: Interim Recommnendations for Schools in the Philippine Setting (August 6, 2020) 

* PPS-PIDSP Joint Statement on Resumption of Immunization Services During COVID-19 Pandemic May 27,2020  

* Clinical Approach to the Management of COVID-19 in Pregnancy and the Newborn – Revised May 7,2020 

* PPS /PIDSP Interim Guidelines on Resumption of Out- Patient Pediatric Clinics Post – Enhanced Community Quarantine During COVID Pandemic 11 May 2020

* Interim Guidelines on the Screening, Assessment and Clinical Management of  Pediatric Patients with Suspected or Confirmed Coronavirus Disease 2019  (COVID-19) Version 2.0  12 April 2020 

* FAQs on COVID-19 IgM/IgG Rapid  Diagnostic Tests as of 1 April 2020 

* Interim Guidelines on the Screening, Assessment and Clinical Management of  Pediatric Patients with Suspected or Confirmed Coronavirus Disease 2019  (COVID-19) 30 March 2020 

* Vaccination during the  COVID-19 Pandemic 

* Approach to the Management of COVID-19 in Pregnancy and the Newborn 

* Information on COVID-19 for Clinicians 

*Support the DOH Vaccination Campaign Against Polio: An Urgent Appeal to the Pediatricians from the Philippine Pediatric Society and the Pediatric Infectious Disease Society of the Philippines 

*Interim Guideline on the Clinical Management of  Patients with  Suspected Confirmed 2019 – Novel Coronavirus (nCoV) Acute Respiratory Disease 

*Polio: Guidance for Clinicians

*PPS-PIDSP Statement of Support – DOH Polio Supplemental

*PPS PIDSP Plea to Immunize 

*Childhood Immunization Schedule 2018 

*PIDSP Dengue FAQs 

*Response from the Pediatric Infectious Disease Society of the Philippines Regarding Current Issues on the Use of the Dengue Vaccine – December 12,2017 

*First Announcement from the PIDSP Board regarding the Dengue Vaccine after the Sanofi release – November 30,2017

*Position Paper on Japanese Encephalitis Vaccines

*Multi-Sectoral Position Statement on the Hepatitis B Vaccine Birth Dose

* Dengue CPG

* Serological Testing Prior to Dengue Vaccine Administration 

* Statement on the use of the Dengue Vaccine

* Combination Vaccine Shortage

* Prevention of Leptospirosis in children

* Interim Statements on the Role of Antibiotic Chemoprophylaxis in Leptospirosis

* Interim Guidelines No. 22 Clinical Management of Suspected and Confirmed Human Pandemic (H1N1) 2009 Infection

* Position Paper of the PIDSP on Preserving the usefulness of Fluoroquinolones